Burlington, Massachusetts–(Newsfile Corp. – January 9, 2025) – Lifordi Immunotherapeutics, Inc., a biotech company developing antibody-drug conjugates (ADCs) for the treatment of autoimmune and inflammatory disorders, today announced the appointment of Matthew W. McClure, M.D., as Chief Medical Officer (CMO). Dr. McClure’s distinguished track record in designing and directing successful early-to-late-stage clinical trials, which include […]